Special to IFN Did you know tobacco use is the leading cause of most preventable deaths in the United States? Although the ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial ...

Researchers have shown that activation of the protein YAP, which helps tumours grow, differs between two- and three-dimensional culture models, pointing to more predictive systems for testing cancer ...

A chance meeting with my childhood friend reminded me — and others— that living with cancer means taking things one day at a time.

Updated findings from a phase 2 study investigating the IL-2–binding monoclonal antibody AU-007 show a manageable safety ...

A group of cancer survivors and supporters from Western New York are traveling to Albany Tuesday to meet with state leaders ...

Returns to FY revenue growth in 2024 (+3.3%), with acceleration in H2 (+10.2%) Slight decrease in operating loss, from €23.1 million in 2023 to €22.5 million in 2024 Operational improvements ...

Phase 1b Beamion LUNG-1 trial data at AACR 2025 showed zongertinib yielded responses in pretreated HER2-mutant NSCLC, ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access.

A group of scientists from the University of the Philippines (UP) Diliman has identified potential biomarkers for lung cancer ...